Dennis Hom

2022

In 2022, Dennis Hom earned a total compensation of $466.9K as Former Chief Financial Officer at Sagimet Biosciences.

Compensation breakdown

Non-Equity Incentive Plan$109,351
Salary$357,473
Other$68
Total$466,892

Hom received $357.5K in salary, accounting for 77% of the total pay in 2022.

Hom also received $109.4K in non-equity incentive plan and $68 in other compensation.

Rankings

In 2022, Dennis Hom's compensation ranked 4,457th out of 5,753 executives tracked by ExecPay. In other words, Hom earned more than 22.5% of executives.

ClassificationRankingPercentile
All
4,457
out of 5,753
23rd
Division
Manufacturing
2,511
out of 3,133
20th
Major group
Chemicals And Allied Products
1,206
out of 1,419
15th
Industry group
Drugs
1,133
out of 1,320
14th
Industry
Pharmaceutical Preparations
826
out of 966
15th
Source: SEC filing on April 18, 2024.

Hom's colleagues

We found three more compensation records of executives who worked with Dennis Hom at Sagimet Biosciences in 2022.

2022

David Happel

Sagimet Biosciences

Chief Executive Officer

2022

George Kemble

Sagimet Biosciences

Chief Executive Officer

2022

Eduardo Martins

Sagimet Biosciences

Chief Medical Officer

News

You may also like